CAR T-Cells and Safety Signals

from Intention to Treat · host NEJM Group

This episode examines CAR T-cell therapy’s early successes, broader promise, and emerging risks, as the FDA considers reports of occasional secondary cancers. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400701.

Episode metadata supplied by the publisher feed · Published Apr 24, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

CAR T-Cells and Safety Signals

0:00 25:25

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Intention to Treat?

This episode is 25 minutes long.

When was this Intention to Treat episode published?

This episode was published on April 24, 2024.

Can I download this Intention to Treat episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!